Published in Lancet on August 29, 1998
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet (2009) 2.81
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ (2014) 2.62
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis. BMJ (2008) 2.09
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart (2005) 1.61
Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. Blood (2011) 1.59
Is provisional stenting the effective option? The WIDEST study (Wiktor stent in de novo stenosis). Widest Trial Investigators' Group. Heart (2000) 1.48
Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses. Biomaterials (2007) 1.17
Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am J Pathol (2000) 1.12
What reimbursement for coronary revascularization with drug-eluting stents? Eur J Health Econ (2004) 1.09
Population need for coronary revascularisation: are national targets for England credible? Heart (2002) 1.03
Long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med (2000) 1.00
Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction. Heart (2001) 0.96
Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res (2011) 0.95
Recent advances in drug eluting stents. Int J Pharm (2012) 0.91
Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach. Am Heart J (2008) 0.87
Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease. Circulation (2013) 0.87
Response of very small (2 mm) porcine coronary arteries to balloon angioplasty and stent implantation. Heart (2004) 0.86
Immediate and Six-month Clinical Outcome of Percutaneous Coronary Intervention in a Tertiary Hospital in the Sultanate of Oman. Oman Med J (2008) 0.85
Delivery of large biopharmaceuticals from cardiovascular stents: a review. Biomacromolecules (2007) 0.83
Plaque stabilisation by systemic and local drug administration. Heart (2004) 0.83
Routine coronary angiographic follow-up and subsequent revascularization in patients with acute myocardial infarction. Heart Vessels (2008) 0.81
Influence of the angiotensin converting enzyme insertion or deletion genetic variant and coronary restenosis risk: evidence based on 11,193 subjects. PLoS One (2013) 0.80
Antiplatelet therapy in patients undergoing coronary stenting: The risk of late stent thrombosis. Neth Heart J (2006) 0.79
Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight. Curr Control Trials Cardiovasc Med (2001) 0.79
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention. Curr Control Trials Cardiovasc Med (2001) 0.79
Treatment for stable coronary artery disease: a network meta-analysis of cost-effectiveness studies. PLoS One (2014) 0.78
Short- and long-term outcomes of single bare metal stent versus drug eluting stent in nondiabetic patients with a simple de novo lesion in the middle and large vessel. J Transl Med (2008) 0.78
Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue Factor. Ann Biomed Eng (2015) 0.77
Completeness of revascularisation by percutaneous coronary intervention. Neth Heart J (2001) 0.75
Early restenosis after drug-eluting stent implantation: A putative role for platelet activation. Can J Cardiol (2007) 0.75
Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting. Clin Res Cardiol (2008) 0.75
Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention. Sultan Qaboos Univ Med J (2010) 0.75
Catheter based intracoronary brachytherapy leads to increased platelet activation. Heart (2004) 0.75
Unstable or High Risk Plaque: How Do We Approach It? Med J Armed Forces India (2011) 0.75
Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. World J Cardiol (2015) 0.75
Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis. Am Heart J (2007) 0.75
Genetic polymorphism of angiotensin converting enzyme and risk of coronary restenosis after percutaneous transluminal coronary angioplasties: evidence from 33 cohort studies. PLoS One (2013) 0.75
Development of a rabbit model for a preclinical comparison of coronary stent types in-vivo. Korean Circ J (2013) 0.75
Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes. Arq Bras Cardiol (2015) 0.75
New developments in endovascular interventions for extracranial carotid stenosis. Tex Heart Inst J (2000) 0.75
Clinical Outcomes from Unselected "Real-World" Patients with Long Coronary Lesion Receiving 40 mm Biodegradable Polymer Coated Sirolimus-Eluting Stent. Scientifica (Cairo) (2015) 0.75
Coronary stents: in these days of climate change should all stents wear coats? Heart (2005) 0.75
Fortnightly review: Intracoronary stents. BMJ (1999) 0.75
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med (1994) 9.15
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet (1997) 6.53
Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med (2001) 6.38
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
The product of a newly identified gene, gInF, is required for synthesis of glutamine synthetase in Salmonella. Proc Natl Acad Sci U S A (1977) 5.19
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Nitrogen control in Salmonella: regulation by the glnR and glnF gene products. Proc Natl Acad Sci U S A (1979) 4.79
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
Improvement of retardates' mealtime behaviors by timeout procedures using multiple baseline techniques. J Appl Behav Anal (1970) 3.97
Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science (1991) 3.56
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation (1996) 3.28
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med (1991) 3.04
Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation (2001) 2.77
Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation (1989) 2.70
New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. Eur Heart J (1999) 2.67
Early clinical experience with the 6 French Angio-Seal device: immediate closure of femoral puncture sites after diagnostic and interventional coronary procedures. Catheter Cardiovasc Interv (2001) 2.62
Searching for autolysin functions. Characterization of a pneumococcal mutant deleted in the lytA gene. Eur J Biochem (1986) 2.58
The training and generalization of a conversational speech form in nonverbal retardates. J Appl Behav Anal (1974) 2.55
Aortic dissection occurring during coronary angioplasty: angiographic and transesophageal echocardiographic findings. Cathet Cardiovasc Diagn (1997) 2.54
Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol (1992) 2.50
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Coronary artery anomalies: a review of more than 10,000 patients from the Clayton Cardiovascular Laboratories. Tex Heart Inst J (1988) 2.48
Nonsurgical retrieval of embolized coronary stents. Catheter Cardiovasc Interv (2000) 2.48
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart (2008) 2.40
Haemodynamic effects of nifedipine in heart failure. Br Heart J (1980) 2.32
Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation (2001) 2.28
Structural organization of virulence-associated plasmids of Yersinia pestis. J Bacteriol (1998) 2.22
Intracranial hypertension in head injury: management and results. Intensive Care Med (1999) 2.21
Alpha-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction. Circulation (1999) 2.20
Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med (1995) 2.19
Short- and long-term evolution of unstented nonocclusive coronary dissection after coronary angioplasty. J Am Coll Cardiol (1999) 2.15
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation (1997) 2.15
Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol (1999) 2.14
Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem (2005) 2.14
Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial vs transfemoral arterial access. Eur Heart J (2000) 2.13
Treatment of a coronary aneurysm with a new polytetrafluoethylene-coated stent: a case report. Catheter Cardiovasc Interv (1999) 2.09
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging. Circulation (1994) 2.06
Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. N Engl J Med (1998) 2.05
Recommendations on stent manufacture, implantation and utilization. Study Group of the Working Group on Coronary Circulation. Eur Heart J (1997) 2.05
A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. Eur Heart J (1999) 1.98
Cerebral protection with filter devices during carotid artery stenting. Circulation (2001) 1.96
Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study) Eur Heart J (1998) 1.95
Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol (1999) 1.94
Stepwise intravascular ultrasound (IVUS) guidance of high-pressure coronary stenting does not result in an improved acute or long-term outcome: a randomized comparison to "final-look" IVUS assessment. Catheter Cardiovasc Interv (1999) 1.93
A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation (1996) 1.90
Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation (2001) 1.89
A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J (2003) 1.83
Interventional therapy of vascular complications caused by the hemostatic puncture closure device angio-seal. Catheter Cardiovasc Interv (2000) 1.76
Long term outcome of patients with postinfarction left ventricular pseudoaneurysm. Heart (2003) 1.76
Primary pulmonary hypertension: effects of nifedipine. Br Heart J (1980) 1.75
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb Investigators. Eur Heart J (2000) 1.73
Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group. Eur Heart J (1998) 1.73
Cutting balloon angioplasty for treatment of calcified coronary lesions. Catheter Cardiovasc Interv (2001) 1.73
Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br J Anaesth (2010) 1.71
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer (2006) 1.70
Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (1996) 1.70
Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy. Circulation (1997) 1.68
Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn (1997) 1.64
Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion. J Am Coll Cardiol (2001) 1.63
A prognostic computer model to predict individual outcome in interventional cardiology. The INTERVENT Project. Eur Heart J (1997) 1.61
The clinical syndrome of atrial myxoma. JAMA (1974) 1.60
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2012) 1.60
Early systolic closure of the aortic valve in patients with hypertrophic subaortic stenosis and discrete subaortic stenosis. Correlation with preoperative and postoperative hemodynamics. Am J Cardiol (1978) 1.60
Irreversible myocardial injury in anoxic perfused rat hearts. Am J Pathol (1975) 1.60
Directional atherectomy prior to stenting in bifurcation lesions: a matched comparison study with stenting alone. Catheter Cardiovasc Interv (2001) 1.59
Intracoronary stenting without coumadin: one month results of a French multicenter study. Cathet Cardiovasc Diagn (1995) 1.59
Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiol Clin (2010) 1.59
[Nasogastric tube: intratracheal malposition and entrapment in a bronchial suture]. Ann Fr Anesth Reanim (1998) 1.59
Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation (1999) 1.58
Effectiveness and complications of vascular access closure devices after interventional procedures. J Invasive Cardiol (2000) 1.57
A randomized comparison of balloon angioplasty versus rotational atherectomy in complex coronary lesions (COBRA study). Eur Heart J (2000) 1.57
Defining a new standard for IVUS optimized drug eluting stent implantation: the PRAVIO study. Catheter Cardiovasc Interv (2009) 1.57
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.57
Exercise-induced ST segment depression in the diagnosis of multivessel coronary disease: a meta analysis. J Am Coll Cardiol (1989) 1.55
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
An integrated metric physical map of human chromosome 19. Nat Genet (1995) 1.54
Biodegradable stents : "fulfilling the mission and stepping away". Circulation (2000) 1.53
Chronic eosinophilic pneumonia as a presenting feature of Churg-Strauss syndrome. Eur Respir J (1994) 1.53
Intracoronary ultrasound observations during stent implantation. Circulation (1994) 1.52
Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.51
Paracervical anesthesia for outpatient hysteroscopy. Fertil Steril (1994) 1.51
Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty. J Am Coll Cardiol (1992) 1.50
Endoscopic transthoracic sympathicotomy for severe angina. Lancet (1995) 1.50
Percutaneous transluminal therapy of occluded saphenous vein grafts: can the challenge be met with ultrasound thrombolysis? Circulation (1999) 1.50